Titin

Not to be confused with Titan, Tintin, or Titian.

VALUE_ERROR (nil)

Identifiers
Aliases|
External IDs| GeneCards: [1]
Orthologs
Species| Human| Mouse
Entrez| |

n/a

n/a

Ensembl| |

n/a

n/a

UniProt| |

n/a

n/a

RefSeq (mRNA)| |

n/a

n/a

RefSeq (protein)| |

n/a

n/a

Location (UCSC)| n/a| n/a
PubMed search| n/a| n/a
Wikidata
| View/Edit Human|

|

Titin /ˈtaɪtɪn/, also known as connectin, is a protein that, in humans, is encoded by the TTN gene.[1][2] Titin is a giant protein, greater than 1 µm in length,[3] that functions as a molecular spring which is responsible for the passive elasticity of muscle. It is composed of 244 individually folded protein domains connected by unstructured peptide sequences.[4] These domains unfold when the protein is stretched and refold when the tension is removed.[5]

Titin is important in the contraction of striated muscle tissues. It connects the Z line to the M line in the sarcomere. The protein contributes to force transmission at the Z line and resting tension in the I band region.[6] It limits the range of motion of the sarcomere in tension, thus contributing to the passive stiffness of muscle. Variations in the sequence of titin between different types of muscle (e.g., cardiac or skeletal) have been correlated with differences in the mechanical properties of these muscles.[1][7]

Titin is the third most abundant protein in muscle (after myosin and actin), and an adult human contains approximately 0.5 kg of titin.[8] With its length of ~27,000 to ~33,000 amino acids (depending on the splice isoform), titin is the largest known protein.[9] Furthermore, the gene for titin contains the largest number of exons (363) discovered in any single gene,[10] as well as the longest single exon (17,106 bp).

## Contents

* 1 Discovery
* 2 Genomics
* 3 Isoforms
* 4 Structure
* 5 Evolution
* 6 Function
* 7 Clinical relevance
* 8 Interactions
* 9 Linguistic significance
* 10 See also
* 11 References
* 12 Further reading
* 13 External links

## Discovery[edit | edit source]

Reiji Natori in 1954 was the first to propose an elastic structure in muscle fiber to account for the return to the resting state when muscles are stretched and then released.[11] In 1977, Koscak Maruyama and coworkers isolated an elastic protein from muscle fiber, which they called connectin.[12] Two years later, Kuan Wang and coworkers identified a doublet band on electrophoresis gel corresponding to a high molecular weight elastic protein, which they named titin.[13][14]

Siegfried Labeit in 1990 isolated a partial cDNA clone of titin.[2] In 1995, Labeit and Bernhard Kolmerer determined the cDNA sequence of human cardiac titin.[4] Labeit and colleagues in 2001 determined the complete sequence of the human titin gene.[10][15]

## Genomics[edit | edit source]

The human gene encoding for titin is located on the long arm of chromosome 2 and contains 363 exons, which together code for 38,138 residues (4200 kDa).[10] Within the gene are found a large number of PEVK (proline-glutamate-valine-lysine -abundant structural motifs) exons 84 to 99 nucleotides in length which code for conserved 28- to 33-residue motifs which may represent structural units of the titin PEVK spring. The number of PEVK motifs in the titin gene appears to have increased during evolution, apparently modifying the genomic region responsible for titin’s spring properties.[16]

## Isoforms[edit | edit source]

A number of titin isoforms are produced in different striated muscle tissues as a result of alternative splicing.[17] All but one of these isoforms are in the range of ~27,000 to ~36,000 amino acid residues in length. The exception is the small cardiac novex-3 isoform which is only 5,604 amino acid residues in length. The following table lists the known titin isoforms:

Isoform | alias/description | length | MW

|
|
|

Q8WZ42-1 | The "canonical" sequence | 34,350 | 3,816,030
Q8WZ42-2 |  | 34,258 | 3,805,708
Q8WZ42-3 | Small cardiac N2-B | 26,926 | 2,992,939
Q8WZ42-4 | Soleus | 33,445 | 3,716,027
Q8WZ42-5 |  | 32,900 | 3,653,085
Q8WZ42-6 | Small cardiac novex-3 | 5,604 | 631,567
Q8WZ42-7 | Cardiac novex-2 | 33,615 | 3,734,648
Q8WZ42-8 | Cardiac novex-1 | 34,475 | 3,829,846
Q8WZ42-9 |  | 27,118 | 3,013,957
Q8WZ42-10 |  | 27,051 | 3,006,755
Q8WZ42-11 |  | 33,423 | 3,713,600
Q8WZ42-12 |  | 35,991 | 3,994,625
Q8WZ42-13 |  | 34,484 | 3,831,069

## Structure[edit | edit source]

Titin is the largest known protein; its human variant consists of 34,350 amino acids, with the molecular weight of the mature "canonical" isoform of the protein being approximately 3,816,188.13 Da.[18] Its mouse homologue is even larger, comprising 35,213 amino acids with a MW of 3,906,487.6 Da.[19] It has a theoretical isoelectric point of 6.01.[18] The protein's empirical chemical formula is C169,719H270,466N45,688O52,238S911.[18] It has a theoretical instability index (II) of 42.41, classifying the protein as unstable.[18] The protein's in vivo half-life, the time it takes for half of the amount of protein in a cell to break down after its synthesis in the cell, is predicted to be approximately 30 hours (in mammalian reticulocytes).[17]

File:Titin IG Domains.jpgTitin Ig domains. a) Schematic of part of a sarcomere b) Structure of Ig domains c) Topology of Ig domains.[20]

The titin protein is located between the myosin thick filament and the Z disk.[21] Titin consists primarily of a linear array of two types of modules, also referred to as protein domains (244 copies in total): type I fibronectin type III domain (132 copies) and type II immunoglobulin domain (112 copies).[8] [4] However, the exact number of these domains is different in different species. This linear array is further organized into two regions:

* N-terminal I-band: acts as the elastic part of the molecule and is composed mainly of type II modules. More specifically the I-band contains two regions of tandem type II immunoglobulin domains on either side of a PEVK region which is rich in proline (P), glutamate (E), valine (V) and lysine (K).[21]
* C-terminal A-band: is thought to act as a protein-ruler and is composed of alternating type I and II modules with super-repeat segments. These have been shown to align to the 43 nm axial repeats of myosin thick filaments with immunoglobulin domains correlating to myosin crowns.[22]

The C-terminal region also contains a serine kinase domain[23][24] that is primarily known for adapting the muscle to mechanical strain.[25] It is “stretch-sensitive” and helps repair overstretching of the sarcomere.[26]

File:Titin IG and FN3 Domains as well as Protein Kinase Domain.pngProtein domains of Titin. White boxes are Fn3 domains, red boxes are Ig domains, yellow boxes are Fn3 domains with the -AVNKYG- sequence, and the black box is protein kinase domain.[27]

The elasticity of the PEVK region has both entropic and enthalpic contributions and is characterized by a polymer persistence length and a stretch modulus.[28] At low to moderate extensions PEVK elasticity can be modeled with a standard worm-like chain (WLC) model of entropic elasticity. At high extensions PEVK stretching can be modeled with a modified WLC model that incorporates enthalpic elasticity. The difference between low-and high- stretch elasticity is due to electrostatic stiffening and hydrophobic effects.

## Evolution[edit | edit source]

The titin domains have evolved from a common ancestor through many gene duplication events.[29] Domain duplication was facilitated by the fact that most domains are encoded by single exons.

Titin has homologs in invertebrates, such as twitchin and projectin, which also contain Ig and FNIII repeats and a protein kinase domain.[26] The gene duplication events took place independently but were from the same ancestral Ig and FNIII domains. It is said that the protein titin was the first to diverge out of the family.[24]

## Function[edit | edit source]

File:Sarcomere.svgSliding filament model of muscle contraction. (Titin labeled at upper right.)

Titin is a large abundant protein of striated muscle. Titin's primary functions are to stabilize the thick filament, center it between the thin filaments, prevent overstretching of the sarcomere, and to recoil the sarcomere like a spring after it is stretched.[30] An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle-associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes.[31][32] Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Of the many titin variants identified, five are described with complete transcript information available.[1][2]

Titin interacts with many sarcomeric proteins including:[10]

* Z line region: telethonin and alpha-actinin
* I band region: calpain-3 and obscurin
* M line region: myosin-binding protein C, calmodulin 1, CAPN3, and MURF1

## Clinical relevance[edit | edit source]

Mutations anywhere within the unusually long sequence of this gene can cause premature stop codons or other defects. Titin mutations are associated with hereditary myopathy with early respiratory failure, early-onset myopathy with fatal cardiomyopathy, core myopathy with heart disease, centronuclear myopathy, limb-girdle muscular dystrophy type 2J, familial dilated cardiomyopathy 9,[6][33] hypertrophic cardiomyopathy and tibial muscular dystrophy.[34] Further research also suggests that no genetically linked form of any dystrophy or myopathy can be safely excluded from being caused by a mutation on the TTN gene.[35] Truncating mutations in dilated cardiomyopathy patients are most commonly found in the A region; although truncations in the upstream I region might be expected to prevent translation of the A region entirely, alternative splicing creates some transcripts that do not encounter the premature stop codon, ameliorating its effect.[36]

Autoantibodies to titin are produced in patients with the autoimmune disease scleroderma.[31]

## Interactions[edit | edit source]

Titin has been shown to interact with:

* ANK1,[37]
* ANKRD1,[38]
* ANKRD23[38]
* CAPN3,[39][40]
* FHL2,[41]
* OBSCN,[42]
* TCAP,[43][44][45][46] and
* TRIM63.[47]

## Linguistic significance[edit | edit source]

The name titin is derived from the Greek Titan (a giant deity, anything of great size).[13]

As the largest known protein, titin also has the longest IUPAC name of a protein. The full chemical name of the human canonical form of titin, which starts methionyl... and ends ...isoleucine, contains 189,819 letters and is sometimes stated to be the longest word in the English language, or of any language.[48] However, lexicographers regard generic names of chemical compounds as verbal formulae rather than English words.[49] The full word can be found here on Wiktionary.

## See also[edit | edit source]

* Longest word in English
* List of protologisms/Long words/Titin (Wiktionary)

## References[edit | edit source]

1. ↑ 1.0 1.1 1.2 "Entrez Gene: TTN titin".
2. ↑ 2.0 2.1 2.2 Labeit S, Barlow DP, Gautel M, Gibson T, Holt J, Hsieh CL, Francke U, Leonard K, Wardale J, Whiting A (May 1990). "A regular pattern of two types of 100-residue motif in the sequence of titin". Nature. 345 (6272): 273–6. doi:10.1038/345273a0. PMID 2129545.
3. ↑ Eric H. Lee. "The Chain-like Elasticity of Titin". Theoretical and Computational Biophysics Group, University of Illinois. Retrieved 25 September 2014.
4. ↑ 4.0 4.1 4.2 Labeit S, Kolmerer B (October 1995). "Titins: giant proteins in charge of muscle ultrastructure and elasticity". Science. 270 (5234): 293–6. doi:10.1126/science.270.5234.293. PMID 7569978.
5. ↑ Minajeva A, Kulke M, Fernandez JM, Linke WA (March 2001). "Unfolding of titin domains explains the viscoelastic behavior of skeletal myofibrils". Biophysical Journal. 80 (3): 1442–51. doi:10.1016/S0006-3495(01)76116-4. PMC 1301335. PMID 11222304.
6. ↑ 6.0 6.1 Itoh-Satoh M, Hayashi T, Nishi H, Koga Y, Arimura T, Koyanagi T, Takahashi M, Hohda S, Ueda K, Nouchi T, Hiroe M, Marumo F, Imaizumi T, Yasunami M, Kimura A (February 2002). "Titin mutations as the molecular basis for dilated cardiomyopathy". Biochemical and Biophysical Research Communications. 291 (2): 385–93. doi:10.1006/bbrc.2002.6448. PMID 11846417.
7. ↑ Online Mendelian Inheritance in Man (OMIM) 188840
8. ↑ 8.0 8.1 Labeit S, Kolmerer B, Linke WA (February 1997). "The giant protein titin. Emerging roles in physiology and pathophysiology". Circulation Research. 80 (2): 290–4. doi:10.1161/01.RES.80.2.290. PMID 9012751.
9. ↑ Opitz CA, Kulke M, Leake MC, Neagoe C, Hinssen H, Hajjar RJ, Linke WA (October 2003). "Damped elastic recoil of the titin spring in myofibrils of human myocardium". Proceedings of the National Academy of Sciences of the United States of America. 100 (22): 12688–93. doi:10.1073/pnas.2133733100. PMC 240679. PMID 14563922.
10. ↑ 10.0 10.1 10.2 10.3 Bang ML, Centner T, Fornoff F, Geach AJ, Gotthardt M, McNabb M, Witt CC, Labeit D, Gregorio CC, Granzier H, Labeit S (November 2001). "The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system". Circulation Research. 89 (11): 1065–72. doi:10.1161/hh2301.100981. PMID 11717165.
11. ↑ Natori R (1954). "Skinned Fibres of Skeletal Muscle and the Mechanism of Muscle Contraction－A Chronological Account of the Author's Investigations into Muscle Physiology" (PDF). Jikeikai Medical Journal. 54 (1).
12. ↑ Maruyama K, Matsubara S, Natori R, Nonomura Y, Kimura S (August 1977). "Connectin, an elastic protein of muscle. Characterization and Function". Journal of Biochemistry. 82 (2): 317–37. PMID 914784.
13. ↑ 13.0 13.1 Wang K, McClure J, Tu A (August 1979). "Titin: major myofibrillar components of striated muscle". Proceedings of the National Academy of Sciences of the United States of America. 76 (8): 3698–702. doi:10.1073/pnas.76.8.3698. PMC 383900. PMID 291034.
14. ↑ Maruyama K (May 1994). "Connectin, an elastic protein of striated muscle". Biophysical Chemistry. 50 (1–2): 73–85. doi:10.1016/0301-4622(94)85021-6. PMID 8011942.
15. ↑ Online Mendelian Inheritance in Man (OMIM) Titin -188840
16. ↑ Freiburg A, Trombitas K, Hell W, Cazorla O, Fougerousse F, Centner T, Kolmerer B, Witt C, Beckmann JS, Gregorio CC, Granzier H, Labeit S. "Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity".
17. ↑ 17.0 17.1 "Titin - Homo sapiens (Human)". Universal Protein Resource. UniProt Consortium. 2010-10-05. Retrieved 2010-10-15.
18. ↑ 18.0 18.1 18.2 18.3 "ProtParam for human titin". ExPASy Proteomics Server. Swiss Institute of Bioinformatics. Retrieved 2011-07-25.
19. ↑ "ProtParam for mouse titin". ExPASy Proteomics Server. Swiss Institute of Bioinformatics. Retrieved 2010-05-06.
20. ↑ Giganti D, Yan K, Badilla CL, Fernandez JM, Alegre-Cebollada J (January 2018). "Disulfide isomerization reactions in titin immunoglobulin domains enable a mode of protein elasticity". Nature Communications. 9 (1): 185. doi:10.1038/s41467-017-02528-7. PMC 5766482. PMID 29330363.
21. ↑ 21.0 21.1 Wang K, McCarter R, Wright J, Beverly J, Ramirez-Mitchell R (August 1991). "Regulation of skeletal muscle stiffness and elasticity by titin isoforms: a test of the segmental extension model of resting tension". Proceedings of the National Academy of Sciences of the United States of America. 88 (16): 7101–5. doi:10.1073/pnas.88.16.7101. PMC 52241. PMID 1714586.
22. ↑ Bennett PM, Gautel M (June 1996). "Titin domain patterns correlate with the axial disposition of myosin at the end of the thick filament". Journal of Molecular Biology. 259 (5): 896–903. doi:10.1006/jmbi.1996.0367. PMID 8683592.
23. ↑ Mayans O, van der Ven PF, Wilm M, Mues A, Young P, Fürst DO, Wilmanns M, Gautel M (October 1998). "Structural basis for activation of the titin kinase domain during myofibrillogenesis". Nature. 395 (6705): 863–9. doi:10.1038/17835. PMID 9804419.
24. ↑ 24.0 24.1 Higgins DG, Labeit S, Gautel M, Gibson TJ (April 1994). "The evolution of titin and related giant muscle proteins". Journal of Molecular Evolution. 38 (4): 395–404. doi:10.1007/BF00163156. PMID 8007007.
25. ↑ Puchner EM, Alexandrovich A, Kho AL, Hensen U, Schäfer LV, Brandmeier B, Gräter F, Grubmüller H, Gaub HE, Gautel M (September 2008). "Mechanoenzymatics of titin kinase". Proceedings of the National Academy of Sciences of the United States of America. 105 (36): 13385–90. doi:10.1073/pnas.0805034105. PMC 2527993. PMID 18765796.
26. ↑ 26.0 26.1 Myhre JL, Pilgrim D (September 2014). "A Titan but not necessarily a ruler: assessing the role of titin during thick filament patterning and assembly". Anatomical Record. 297 (9): 1604–14. doi:10.1002/ar.22987. PMID 25125174.
27. ↑ Mikelsaar AV, Sünter A, Mikelsaar R, Toomik P, Kõiveer A, Mikelsaar I, Juronen E (September 2012). "Epitope of titin A-band-specific monoclonal antibody Tit1 5 H1.1 is highly conserved in several Fn3 domains of the titin molecule. Centriole staining in human, mouse and zebrafish cells". Cell Division. 7 (1): 21. doi:10.1186/1747-1028-7-21. PMC 3541999. PMID 22985877.
28. ↑ Linke WA, Ivemeyer M, Mundel P, Stockmeier MR, Kolmerer B (July 1998). "Nature of PEVK-titin elasticity in skeletal muscle". Proceedings of the National Academy of Sciences of the United States of America. 95 (14): 8052–7. doi:10.1073/pnas.95.14.8052. PMC 20927. PMID 9653138.
29. ↑ Tskhovrebova L, Trinick J (November 2004). "Properties of titin immunoglobulin and fibronectin-3 domains". The Journal of Biological Chemistry. 279 (45): 46351–4. doi:10.1074/jbc.r400023200. PMID 15322090.
30. ↑ Saladin K (2015). Anatomy & Physiology (7th ed.). McGraw Hill. p. 401\. ISBN 978-0-07-340371-7.
31. ↑ 31.0 31.1 Machado C, Sunkel CE, Andrew DJ (April 1998). "Human autoantibodies reveal titin as a chromosomal protein". The Journal of Cell Biology. 141 (2): 321–33. doi:10.1083/jcb.141.2.321. PMC 2148454. PMID 9548712.
32. ↑ Machado C, Andrew DJ (2000). "Titin as a chromosomal protein". Advances in Experimental Medicine and Biology. 481: 221–32, discussion 232–6. doi:10.1007/978-1-4615-4267-4_13. PMID 10987075.
33. ↑ Siu BL, Niimura H, Osborne JA, Fatkin D, MacRae C, Solomon S, Benson DW, Seidman JG, Seidman CE (March 1999). "Familial dilated cardiomyopathy locus maps to chromosome 2q31". Circulation. 99 (8): 1022–6. doi:10.1161/01.cir.99.8.1022. PMID 10051295.
34. ↑ Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, Labeit S, Witt C, Peltonen L, Richard I, Udd B (September 2002). "Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin". American Journal of Human Genetics. 71 (3): 492–500. doi:10.1086/342380. PMC 379188. PMID 12145747.
35. ↑ Udd B, Vihola A, Sarparanta J, Richard I, Hackman P (February 2005). "Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J". Neurology. 64 (4): 636–42. doi:10.1212/01.WNL.0000151853.50144.82. PMID 15728284.
36. ↑ Hinson JT, Chopra A, Nafissi N, Polacheck WJ, Benson CC, Swist S, et al. (August 2015). "HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy". Science. 349 (6251): 982–6. doi:10.1126/science.aaa5458. PMC 4618316. PMID 26315439.
37. ↑ Kontrogianni-Konstantopoulos A, Bloch RJ (February 2003). "The hydrophilic domain of small ankyrin-1 interacts with the two N-terminal immunoglobulin domains of titin". The Journal of Biological Chemistry. 278 (6): 3985–91. doi:10.1074/jbc.M209012200. PMID 12444090.
38. ↑ 38.0 38.1 Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, et al. (November 2003). "The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules". Journal of Molecular Biology. 333 (5): 951–64. doi:10.1016/j.jmb.2003.09.012. PMID 14583192.
39. ↑ Ono Y, Shimada H, Sorimachi H, Richard I, Saido TC, Beckmann JS, Ishiura S, Suzuki K (July 1998). "Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A". The Journal of Biological Chemistry. 273 (27): 17073–8. doi:10.1074/jbc.273.27.17073. PMID 9642272.
40. ↑ Sorimachi H, Kinbara K, Kimura S, Takahashi M, Ishiura S, Sasagawa N, Sorimachi N, Shimada H, Tagawa K, Maruyama K (December 1995). "Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence". The Journal of Biological Chemistry. 270 (52): 31158–62. doi:10.1074/jbc.270.52.31158. PMID 8537379.
41. ↑ Lange S, Auerbach D, McLoughlin P, Perriard E, Schäfer BW, Perriard JC, Ehler E (December 2002). "Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2". Journal of Cell Science. 115 (Pt 24): 4925–36. doi:10.1242/jcs.00181. PMID 12432079.
42. ↑ Young P, Ehler E, Gautel M (July 2001). "Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly". The Journal of Cell Biology. 154 (1): 123–36. doi:10.1083/jcb.200102110. PMC 2196875. PMID 11448995.
43. ↑ Gregorio CC, Trombitás K, Centner T, Kolmerer B, Stier G, Kunke K, Suzuki K, Obermayr F, Herrmann B, Granzier H, Sorimachi H, Labeit S (November 1998). "The NH2 terminus of titin spans the Z-disc: its interaction with a novel 19-kD ligand (T-cap) is required for sarcomeric integrity". The Journal of Cell Biology. 143 (4): 1013–27. doi:10.1083/jcb.143.4.1013. PMC 2132961. PMID 9817758.
44. ↑ Mayans O, van der Ven PF, Wilm M, Mues A, Young P, Fürst DO, Wilmanns M, Gautel M (October 1998). "Structural basis for activation of the titin kinase domain during myofibrillogenesis". Nature. 395 (6705): 863–9. doi:10.1038/27603. PMID 9804419.
45. ↑ Zou P, Gautel M, Geerlof A, Wilmanns M, Koch MH, Svergun DI (January 2003). "Solution scattering suggests cross-linking function of telethonin in the complex with titin". The Journal of Biological Chemistry. 278 (4): 2636–44. doi:10.1074/jbc.M210217200. PMID 12446666.
46. ↑ Mues A, van der Ven PF, Young P, Fürst DO, Gautel M (May 1998). "Two immunoglobulin-like domains of the Z-disc portion of titin interact in a conformation-dependent way with telethonin". FEBS Letters. 428 (1–2): 111–4. doi:10.1016/S0014-5793(98)00501-8. PMID 9645487.
47. ↑ Centner T, Yano J, Kimura E, McElhinny AS, Pelin K, Witt CC, Bang ML, Trombitas K, Granzier H, Gregorio CC, Sorimachi H, Labeit S (March 2001). "Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain". Journal of Molecular Biology. 306 (4): 717–26. doi:10.1006/jmbi.2001.4448. PMID 11243782.
48. ↑ McCulloch S. "Longest word in English". Sarah McCulloch.com. Archived from the original on 2010-01-14. Retrieved 2016-10-12.
49. ↑ Oxford Word and Language Service team. "Ask the experts - What is the longest English word?". AskOxford.com / Oxford University Press. Archived from the original on 2008-09-13. Retrieved 2008-01-13.

## Further reading[edit | edit source]

* Tskhovrebova L, Trinick J (September 2003). "Titin: properties and family relationships". Nature Reviews Molecular Cell Biology. 4 (9): 679–89. doi:10.1038/nrm1198. PMID 14506471.
* Kinbara K, Sorimachi H, Ishiura S, Suzuki K (August 1998). "Skeletal muscle-specific calpain, p49: structure and physiological function". Biochemical Pharmacology. 56 (4): 415–20. doi:10.1016/S0006-2952(98)00095-1. PMID 9763216.
* Kolmerer B, Witt CC, Freiburg A, Millevoi S, Stier G, Sorimachi H, Pelin K, Carrier L, Schwartz K, Labeit D, Gregorio CC, Linke WA, Labeit S (1999). "The titin cDNA sequence and partial genomic sequences: insights into the molecular genetics, cell biology and physiology of the titin filament system". Reviews of Physiology, Biochemistry and Pharmacology. 138: 19–55. doi:10.1007/BF02346659. PMID 10396137.
* Trinick J, Tskhovrebova L (October 1999). "Titin: a molecular control freak". Trends in Cell Biology. 9 (10): 377–80. doi:10.1016/S0962-8924(99)01641-4. PMID 10481174.
* Sorimachi H, Ono Y, Suzuki K (2000). "Skeletal muscle-specific calpain, p94, and connectin/titin: their physiological functions and relationship to limb-girdle muscular dystrophy type 2A". Advances in Experimental Medicine and Biology. 481: 383–95, discussion 395–7. doi:10.1007/978-1-4615-4267-4_23. PMID 10987085.
* Tskhovrebova L, Trinick J (February 2002). "Role of titin in vertebrate striated muscle". Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 357 (1418): 199–206. doi:10.1098/rstb.2001.1028. PMC 1692937. PMID 11911777.
* Sela BA (July 2002). "[Titin: some aspects of the largest protein in the body]". Harefuah. 141 (7): 631–5, 665. PMID 12187564.
* Tskhovrebova L, Trinick J (November 2004). "Properties of titin immunoglobulin and fibronectin-3 domains". The Journal of Biological Chemistry. 279 (45): 46351–4. doi:10.1074/jbc.R400023200. PMID 15322090.
* Wu Y, Labeit S, Lewinter MM, Granzier H (December 2002). "Titin: an endosarcomeric protein that modulates myocardial stiffness in DCM". Journal of Cardiac Failure. 8 (6 Suppl): S276–86. doi:10.1054/jcaf.2002.129278. PMID 12555133.

## External links[edit | edit source]

File:Wiktionary-logo-en-v2.svg | Look up the full chemical name of titin in Wiktionary, the free dictionary.

|

* GeneReviews/NIH/NCBI/UW entry on Familial Hypertrophic Cardiomyopathy Overview
* GeneReviews/NCBI/NIH/UW entry on Udd Distal Myopathy, Tibial Muscular Dystrophy, Udd Myopathy
* GeneReviews/NIH/NCBI/UW entry on Salih Myopathy or Early-Onset Myopathy with Fatal Cardiomyopathy

* v
* t
* e

PDB gallery

* 1bpv: TITIN MODULE A71 FROM HUMAN CARDIAC MUSCLE, NMR, 50 STRUCTURES

1bpv: TITIN MODULE A71 FROM HUMAN CARDIAC MUSCLE, NMR, 50 STRUCTURES

* 1g1c: I1 DOMAIN FROM TITIN

1g1c: I1 DOMAIN FROM TITIN

* 1h8b: EF-HANDS 3,4 FROM ALPHA-ACTININ / Z-REPEAT 7 FROM TITIN

1h8b: EF-HANDS 3,4 FROM ALPHA-ACTININ / Z-REPEAT 7 FROM TITIN

* 1nct: TITIN MODULE M5, N-TERMINALLY EXTENDED, NMR

1nct: TITIN MODULE M5, N-TERMINALLY EXTENDED, NMR

* 1ncu: Titin Module M5, N-terminally Extended, NMR

1ncu: Titin Module M5, N-terminally Extended, NMR

* 1tit: TITIN, IG REPEAT 27, NMR, MINIMIZED AVERAGE STRUCTURE

1tit: TITIN, IG REPEAT 27, NMR, MINIMIZED AVERAGE STRUCTURE

* 1tiu: TITIN, IG REPEAT 27, NMR, 24 STRUCTURES

1tiu: TITIN, IG REPEAT 27, NMR, 24 STRUCTURES

* 1tki: AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN

1tki: AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN

* 1tnm: TERTIARY STRUCTURE OF AN IMMUNOGLOBULIN-LIKE DOMAIN FROM THE GIANT MUSCLE PROTEIN TITIN: A NEW MEMBER OF THE I SET

1tnm: TERTIARY STRUCTURE OF AN IMMUNOGLOBULIN-LIKE DOMAIN FROM THE GIANT MUSCLE PROTEIN TITIN: A NEW MEMBER OF THE I SET

* 1tnn: Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: a new member of the I set

1tnn: Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: a new member of the I set

* 1waa: IG27 PROTEIN DOMAIN

1waa: IG27 PROTEIN DOMAIN

* 1ya5: Crystal structure of the titin domains z1z2 in complex with telethonin

1ya5: Crystal structure of the titin domains z1z2 in complex with telethonin

* 2a38: Crystal structure of the N-Terminus of titin

2a38: Crystal structure of the N-Terminus of titin

* 2bk8: M1 DOMAIN FROM TITIN

2bk8: M1 DOMAIN FROM TITIN

* 2f8v: Structure of full length telethonin in complex with the N-terminus of titin

2f8v: Structure of full length telethonin in complex with the N-terminus of titin

* 2ill: Anomalous substructure of Titin-A168169

2ill: Anomalous substructure of Titin-A168169

* 2nzi: Crystal structure of domains A168-A170 from titin

2nzi: Crystal structure of domains A168-A170 from titin

* v
* t
* e

Proteins of the cytoskeleton

Human|

| Microfilaments
and ABPs|

| Myofilament|

| Actins|

* A1
* A2
* B
* C1
* G1
* G2

|

Myosins|

* I
* MYO1A
* MYO1B
* MYO1C
* MYO1D
* MYO1E
* MYO1F
* MYO1G
* MYO1H)
* II
* MYH1
* MYH2
* MYH3
* MYH4
* MYH6
* MYH7
* MYH7B
* MYH8
* MYH9
* MYH10
* MYH11
* MYH13
* MYH14
* MYH15
* MYH16
* III
* MYO3A
* MYO3B
* V
* MYO5A
* MYO5B
* MYO5C
* VI
* MYO6
* VII
* MYO7A
* MYO7B
* IX
* MYO9A
* MYO9B
* X
* MYO10
* XV
* MYO15A
* XVIII
* MYO18A
* MYO18B
* LC
* MYL1
* MYL2
* MYL3
* MYL4
* MYL5
* MYL6
* MYL6B
* MYL7
* MYL9
* MYLIP
* MYLK
* MYLK2
* MYLL1

Other|

* Tropomodulin
* 1
* 2
* 3
* 4
* Troponin
* T 1 2 3
* C 1 2
* I 1 2 3
* Tropomyosin
* 1
* 2
* 3
* 4

* Actinin
* 1
* 2
* 3
* 4
* Arp2/3 complex
* actin depolymerizing factors
* Cofilin
* 1
* 2
* Destrin
* Gelsolin
* Profilin
* 1
* 2
* Titin

Other|

* Wiskott-Aldrich syndrome protein
* Fibrillin
* Filamin
* FLNA
* FLNB
* FLNC
* Espin
* TRIOBP

Intermediate
filaments|

| Type 1/2
(Keratin,
Cytokeratin)|

| Epithelial keratins
(soft alpha-keratins)|

* type I/chromosome 17
* 10
* 12
* 13
* 14
* 15
* 16
* 17
* 19
* 20
* chromosome 12
* 18
* none
* 21

* type II/chromosome 12
* 1
* 2A
* 3
* 4
* 5
* 6A
* 6B
* 7
* 8
* 9

|

Hair keratins
(hard alpha-keratins)|

* type I/chromosome 17
* 31
* 32
* 33A
* 33B
* 34
* 35
* 36
* 37
* 38

* type II/chromosome 12
* 81
* 82
* 83
* 84
* 85
* 86

Ungrouped alpha|

* chromosome 17
* 23
* 24
* 25
* 26
* 27
* 28
* 39
* 40

* chromosome 12
* 71
* 72
* 73
* 74
* 75
* 76
* 77
* 78
* 79
* 80

Not alpha|

* Beta-keratin

Type 3|

* Desmin
* GFAP
* Peripherin
* Vimentin

Type 4|

* Internexin
* Nestin
* Neurofilament
* NEFL
* NEFM
* NEFH
* Synemin
* Syncoilin

Type 5|

* Nuclear lamins: A/C
* B1
* B2

Microtubules
and MAPs|

| Tubulins|

* TUBA1A
* TUBA1B
* TUBA1C
* TUBA3C
* TUBA3D
* TUBA3E
* TUBA4A
* TUBA8

|

Kinesins|

* KIF1A
* KIF1B
* KIF2A
* KIF2C
* KIF3B
* KIF3C
* KIF4A
* KIF4B
* KIF5A
* KIF5B
* KIF5C
* KIF6
* KIF7
* KIF9
* KIF11
* KIF12
* KIF13A
* KIF13B
* KIF14
* KIF15
* KIF16B
* KIF17
* KIF18A
* KIF18B
* KIF19
* KIF20A
* KIF20B
* KIF21A
* KIF21B
* KIF22
* KIF23
* KIF24
* KIF25
* KIF26A
* KIF26B
* KIF27
* KIFC1
* KIFC2
* KIFC3

Dyneins|

* axonemal: DNAH1
* DNAH2
* DNAH3
* DNAH5
* DNAH6
* DNAH7
* DNAH8
* DNAH9
* DNAH10
* DNAH11
* DNAH12
* DNAH13
* DNAH14
* DNAH17
* DNAI1
* DNAI2
* DNALI1
* DNAL1
* DNAL4

* cytoplasmic: DYNC1H1
* DYNC2H1
* DYNC1I1
* DYNC1I2
* DYNC1LI1
* DYNC1LI2
* DYNC2LI1
* DYNLL1
* DYNLL2
* DYNLRB1
* DYNLRB2
* DYNLT1
* DYNLT3

Other|

* Tau protein
* Dynactin
* DCTN1
* Stathmin
* Tektin
* TEKT1
* TEKT2
* TEKT3
* TEKT4
* TEKT5
* Dynamin
* DNM1
* DNM2
* DNM3

Catenins|

* Alpha catenin
* Beta catenin
* APC
* Plakoglobin (gamma catenin)
* Delta catenin
* GAN

Membrane|

* Dystrophin
* Dystroglycan
* Utrophin
* Ankyrin
* ANK1
* ANK2
* ANK3
* Spectrin
* SPTA1
* SPTAN1
* SPTB
* SPTBN1
* SPTBN2
* SPTBN4
* SPTBN5

Other|

* Plakins
* Corneodesmosin
* Desmoplakin
* Dystonin
* Envoplakin
* MACF1
* Periplakin
* Plectin
* Talin
* TLN1
* Vinculin
* Plakophilin
* PKP1
* PKP2

Nonhuman|

* Major sperm proteins
* Prokaryotic cytoskeleton
* Crescentin
* FtsZ
* MreB

See also: cytoskeletal defects

* v
* t
* e

Muscle tissue

Smooth
muscle|

* Calmodulin
* Vascular smooth muscle

Striated
muscle|

| Skeletal
muscle|

| Costamere/
DAPC|

| Membrane/
extracellular|

| DAP:|

* Sarcoglycan
* SGCA
* SGCB
* SGCD
* SGCE
* SGCG
* SGCZ
* Dystroglycan

|

* Sarcospan
* Laminin, alpha 2

Intracellular|

* Dystrophin
* Dystrobrevin
* A
* B
* Syntrophin
* A
* B1
* B2
* G1
* G2
* Syncoilin
* Dysbindin
* Synemin/desmuslin

related:|

* NOS1
* Caveolin 3

Sarcomere/
(a, i, and h bands;
z and m lines)|

* Myofilament
* thin filament/actin
* thick filament/myosin
* elastic filament/titin
* nebulin

* Tropomyosin

* Troponin
* T
* C
* I

Connective tissue|

* Epimysium
* Fascicle
* Perimysium
* Endomysium
* Connective tissue in skeletal muscle

General|

* Neuromuscular junction
* Motor unit
* Muscle spindle
* Excitation–contraction coupling
* Sliding filament mechanism

Cardiac
muscle|

* Myocardium
* Intercalated disc
* Nebulette

Both|

| Fiber|

* Muscle fiber
* intrafusal
* extrafusal
* Myofibril
* Microfilament/Myofilament
* Sarcomere

|

Cells|

* Myoblast/Myocyte
* Myosatellite cell

Other|

* Desmin
* Sarcoplasm
* Sarcolemma
* T-tubule
* Sarcoplasmic reticulum

Other/
ungrouped|

* Myotilin
* Telethonin
* Dysferlin
* Fukutin
* Fukutin-related protein

* v
* t
* e

Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12)

Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20)

| Non-specific serine/threonine protein kinases (EC 2.7.11.1)|

* LATS1
* LATS2
* MAST1
* MAST2
* STK38
* STK38L
* CIT
* ROCK1
* SGK
* SGK2
* SGK3
* Protein kinase B
* AKT1
* AKT2
* AKT3
* Ataxia telangiectasia mutated
* mTOR
* EIF-2 kinases
* PKR
* HRI
* EIF2AK3
* EIF2AK4
* Wee1
* WEE1

|

Pyruvate dehydrogenase kinase (EC 2.7.11.2)|

* PDK1
* PDK2
* PDK3
* PDK4

Dephospho-(reductase kinase) kinase (EC 2.7.11.3)|

* AMP-activated protein kinase α
* PRKAA1
* PRKAA2
* β
* PRKAB1
* PRKAB2
* γ
* PRKAG1
* PRKAG2
* PRKAG3

3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring) kinase (EC 2.7.11.4)|

* BCKDK
* BCKDHA
* BCKDHB

(isocitrate dehydrogenase (NADP+)) kinase (EC 2.7.11.5)|

* IDH2
* IDH3A
* IDH3B
* IDH3G

(tyrosine 3-monooxygenase) kinase (EC 2.7.11.6)|

* STK4

Myosin-heavy-chain kinase (EC 2.7.11.7)|

* Aurora kinase
* Aurora A kinase
* Aurora B kinase
* Aurora C kinase

Fas-activated serine/threonine kinase (EC 2.7.11.8)|

* FASTK
* STK10

Goodpasture-antigen-binding protein kinase (EC 2.7.11.9)|

* -

IκB kinase (EC 2.7.11.10)|

* CHUK
* IKK2
* TBK1
* IKBKE
* IKBKG
* IKBKAP

cAMP-dependent protein kinase (EC 2.7.11.11)|

* Protein kinase A
* PRKACG
* PRKACB
* PRKACA
* PRKY

cGMP-dependent protein kinase (EC 2.7.11.12)|

* Protein kinase G
* PRKG1

Protein kinase C (EC 2.7.11.13)|

* Protein kinase C
* Protein kinase Cζ
* PKC alpha
* PRKCB1
* PRKCD
* PRKCE
* PRKCH
* PRKCG
* PRKCI
* PRKCQ
* Protein kinase N1
* PKN2
* PKN3

Rhodopsin kinase (EC 2.7.11.14)|

* Rhodopsin kinase

Beta adrenergic receptor kinase (EC 2.7.11.15)|

* Beta adrenergic receptor kinase
* Beta adrenergic receptor kinase-2

G-protein coupled receptor kinases (EC 2.7.11.16)|

* GRK4
* GRK5
* GRK6

Ca2+/calmodulin-dependent (EC 2.7.11.17)|

* BRSK2
* CAMK1
* CAMK1A
* CAMK1B
* CAMK1D
* CAMK1G
* CAMK2
* CAMK2A
* CAMK2B
* CAMK2D
* CAMK2G
* CAMK4
* MLCK
* CASK
* CHEK1
* CHEK2
* DAPK1
* DAPK2
* DAPK3
* STK11
* MAPKAPK2
* MAPKAPK3
* MAPKAPK5
* MARK1
* MARK2
* MARK3
* MARK4
* MELK
* MKNK1
* MKNK2
* NUAK1
* NUAK2
* OBSCN
* PASK
* PHKG1
* PHKG2
* PIM1
* PIM2
* PKD1
* PRKD2
* PRKD3
* PSKH1
* SNF1LK2
* KIAA0999
* STK40
* SNF1LK
* SNRK
* SPEG
* TSSK2
* Kalirin
* TRIB1
* TRIB2
* TRIB3
* TRIO
* Titin
* DCLK1

Myosin light-chain kinase (EC 2.7.11.18)|

* MYLK
* MYLK2
* MYLK3
* MYLK4

Phosphorylase kinase (EC 2.7.11.19)|

* PHKA1
* PHKA2
* PHKB
* PHKG1
* PHKG2

Elongation factor 2 kinase (EC 2.7.11.20)|

* EEF2K
* STK19

Polo kinase (EC 2.7.11.21)|

* PLK1
* PLK2
* PLK3
* PLK4

Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)

| Polo kinase (EC 2.7.11.21)|

* PLK1
* PLK2
* PLK3
* PLK4

|

Cyclin-dependent kinase (EC 2.7.11.22)|

* CDK1
* CDK2
* CDKL2
* CDK3
* CDK4
* CDK5
* CDKL5
* CDK6
* CDK7
* CDK8
* CDK9
* CDK10
* CDK12
* CDC2L5
* PCTK1
* PCTK2
* PCTK3
* PFTK1
* CDC2L1

(RNA-polymerase)-subunit kinase (EC 2.7.11.23)|

* RPS6KA5
* RPS6KA4
* P70S6 kinase
* P70-S6 Kinase 1
* RPS6KB2
* RPS6KA2
* RPS6KA3
* RPS6KA1
* RPS6KC1

Mitogen-activated protein kinase (EC 2.7.11.24)|

* Extracellular signal-regulated
* MAPK1
* MAPK3
* MAPK4
* MAPK6
* MAPK7
* MAPK12
* MAPK15
* C-Jun N-terminal
* MAPK8
* MAPK9
* MAPK10
* P38 mitogen-activated protein
* MAPK11
* MAPK13
* MAPK14

MAP3K (EC 2.7.11.25)|

* MAP kinase kinase kinases
* MAP3K1
* MAP3K2
* MAP3K3
* MAP3K4
* MAP3K5
* MAP3K6
* MAP3K7
* MAP3K8
* RAFs
* ARAF
* BRAF
* KSR1
* KSR2
* MLKs
* MAP3K12
* MAP3K13
* MAP3K9
* MAP3K10
* MAP3K11
* MAP3K7
* ZAK
* CDC7
* MAP3K14

Tau-protein kinase (EC 2.7.11.26)|

* TPK1
* TTK
* GSK-3

(acetyl-CoA carboxylase) kinase (EC 2.7.11.27)|

* -

Tropomyosin kinase (EC 2.7.11.28)|

* -

Low-density-lipoprotein receptor kinase (EC 2.7.11.29)|

* -

Receptor protein serine/threonine kinase (EC 2.7.11.30)|

* Bone morphogenetic protein receptors
* BMPR1
* BMPR1A
* BMPR1B
* BMPR2
* ACVR1
* ACVR1B
* ACVR1C
* ACVR2A
* ACVR2B
* ACVRL1
* Anti-Müllerian hormone receptor

Dual-specificity kinases (EC 2.7.12)

| MAP2K|

* MAP2K1
* MAP2K2
* MAP2K3
* MAP2K4
* MAP2K5
* MAP2K6
* MAP2K7

|

* v
* t
* e

Enzymes

Activity|

* Active site
* Binding site
* Catalytic triad
* Oxyanion hole
* Enzyme promiscuity
* Catalytically perfect enzyme
* Coenzyme
* Cofactor
* Enzyme catalysis

Regulation|

* Allosteric regulation
* Cooperativity
* Enzyme inhibitor
* Enzyme activator

Classification|

* EC number
* Enzyme superfamily
* Enzyme family
* List of enzymes

Kinetics|

* Enzyme kinetics
* Eadie–Hofstee diagram
* Hanes–Woolf plot
* Lineweaver–Burk plot
* Michaelis–Menten kinetics

Types|

* EC1 Oxidoreductases (list)
* EC2 Transferases (list)
* EC3 Hydrolases (list)
* EC4 Lyases (list)
* EC5 Isomerases (list)
* EC6 Ligases (list)

This article incorporates text from the United States National Library of Medicine, which is in the public domain.
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template